SCHEMBL29698917

SCHEMBL29698917

CCC(=O)NC(C)(C)C(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.66
HDAC3 O15379 1/20 0.60
HDAC4 P56524 1/20 0.60
HDAC1 Q13547 1/20 0.60
HDAC7 Q8WUI4 1/20 0.60
HDAC2 Q92769 1/20 0.60
HDAC10 Q969S8 1/20 0.60
HDAC11 Q96DB2 1/20 0.60
HDAC8 Q9BY41 1/20 0.60
HDAC6 Q9UBN7 1/20 0.60
HDAC9 Q9UKV0 1/20 0.60
HDAC5 Q9UQL6 1/20 0.60
CSNK1D P48730 4/20 0.58
WNT3A P56704 1/20 0.54
HIF1A Q16665 1/20 0.53
ACP1 P24666 1/20 0.52
NPC1 O15118 6/20 0.51
RAB9A P51151 6/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18154305 0.91 DYRK1A (0.65) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154239 0.90 DYRK1A (0.61) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154294 0.90 DYRK1A (0.64) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL30128662 0.89 DYRK1A (0.62) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154332 0.89 DYRK1A (0.62) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL21729400 0.88 DYRK1A (0.76) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154360 0.88 DYRK1A (0.69) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL30795396 0.88 DYRK1A (0.69) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154098 0.88 DYRK1A (0.60) DYRK1AHDAC3HDAC4HDAC1HDAC7
SCHEMBL18154318 0.86 DYRK1A (0.64) DYRK1AHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4011870-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING RILUZOLE PRODRUGS Biohaven Pharmaceutical Holding Company Ltd. (US) 2022-06-15 EP disclosed